Loading
LOADING
Twice weekly SubQ is the standard dosing from the international clinical use. Tα1's tolerability supports long-duration administration — this isn't a short-cycle peptide.
Protocol mirrors what's used in hepatitis and immune-deficient cancer adjunct trials internationally.
| Compound | Dose | Frequency | Route |
|---|---|---|---|
| Thymosin Alpha-1 | 1.6mg | 2x weekly | SubQ |
No comments yet. Start the thread.